Altus Wealth Group’s Pfizer PFE Stock Holding History
Bought
Maintained
Sold
Other funds holding PFE
Altus Wealth Group's PFE Position: Q2 2025 in Review
Altus Wealth Group sold out of Pfizer (PFE) in Q2 2025, closing a stake of 7,995 shares — an estimated $203K sold.
Altus Wealth Group first reported a position in PFE in Q4 2020 and held it in 18 quarters. The position peaked at $802K in Q4 2021. 2,809 funds tracked by Wall St. Rank hold PFE as of Q2 2025.
- Altus Wealth Group reported no remaining Pfizer position as of Q2 2025 after selling out during the quarter.
- Altus Wealth Group sold 7,995 Pfizer shares in Q2 2025, an estimated $203K.
- Altus Wealth Group first reported a position in Pfizer in Q4 2020 and held it in 18 quarters.
- Altus Wealth Group's Pfizer position peaked at $802K in Q4 2021.
- 2,809 funds tracked by Wall St. Rank held Pfizer as of Q2 2025.
Based on Altus Wealth Group's 13F filing for Q2 2025, filed 29 Jul 2025.